BVF INC/IL - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 64 filers reported holding ARCUS BIOSCIENCES INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
BVF INC/IL ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q4 2022$47,636,794
-33.0%
2,303,520
-15.2%
2.01%
-31.5%
Q3 2022$71,077,000
-29.2%
2,717,020
-31.4%
2.94%
-39.4%
Q2 2022$100,370,000
-19.7%
3,960,9480.0%4.85%
-3.1%
Q1 2022$125,008,000
-9.1%
3,960,948
+16.6%
5.00%
+0.2%
Q4 2021$137,520,000
+22.1%
3,398,067
+5.2%
4.99%
+13.6%
Q3 2021$112,624,000
+46.6%
3,229,822
+15.4%
4.39%
+52.6%
Q2 2021$76,828,000
+45.8%
2,797,822
+49.1%
2.88%
+45.8%
Q1 2021$52,682,000
-26.3%
1,876,122
-31.8%
1.98%
-29.7%
Q4 2020$71,448,000
+60.5%
2,752,222
+6.0%
2.81%
+16.0%
Q3 2020$44,516,000
-4.4%
2,597,222
+38.0%
2.42%
-15.6%
Q2 2020$46,579,000
+8606.4%
1,882,722
+4780.8%
2.87%
+5644.0%
Q1 2020$535,000
-98.5%
38,574
-98.9%
0.05%
-98.2%
Q4 2019$36,148,000
+11.0%
3,579,0230.0%2.74%
-19.9%
Q3 2019$32,569,000
+15.9%
3,579,023
+1.2%
3.42%
+11.5%
Q2 2019$28,105,000
-19.9%
3,535,223
+25.8%
3.07%
-21.9%
Q1 2019$35,100,000
+35.1%
2,810,223
+16.5%
3.93%
+15.8%
Q4 2018$25,973,000
+76.0%
2,411,623
+127.8%
3.39%
+161.7%
Q3 2018$14,760,000
+25.6%
1,058,840
+10.3%
1.30%
+13.1%
Q2 2018$11,748,000
-40.1%
959,840
-24.4%
1.15%
-42.3%
Q1 2018$19,606,0001,269,7881.99%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q2 2018
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$28,936,78218.14%
Octagon Capital Advisors LP 1,968,000$35,325,6005.43%
Decheng Capital Management III (Cayman), LLC 869,790$15,612,7315.21%
Boxer Capital, LLC 1,602,200$28,759,4901.53%
SECTORAL ASSET MANAGEMENT INC 375,456$6,739,4351.31%
DAFNA Capital Management LLC 222,717$3,997,7701.24%
PFM Health Sciences, LP 1,405,056$25,220,7551.19%
Ikarian Capital, LLC 4,000$7,180,0000.86%
Capital Impact Advisors, LLC 24,280$435,8260.73%
Parkman Healthcare Partners LLC 205,109$3,681,7070.68%
View complete list of ARCUS BIOSCIENCES INC shareholders